Yi Feng Feng

Yi Feng Feng currently works at Sinopharm Holding Henan Co., Ltd., as Director from 2012, Sinopharm Holding Hainan Co., Ltd., as Director from 2012, Sinopharm Holding Fujian Co., Ltd., as Director from 2012, Shanghai Chicmax Cosmetics Co., Ltd., as Chief Financial Officer & Executive Director from 2016, Shanghai Yuzi Technology Co. Ltd., as Executive Director from 2017, Shanghai KPC Biotechnology Co. Ltd., as Director from 2020, Shanghai Teaz Cosmetic Co. Ltd., as Director from 2021, Sinopharm Chemical Reagent Co., Ltd., as Member-Supervisory Board from 2012, Sinopharm Holding Changzhou Co. Ltd., as Member-Supervisory Board from 2010, Sinopharm Holding Wuxi Co. Ltd., as Member-Supervisory Board from 2012, Sinopharm Holding Gansu Co., Ltd., as Member-Supervisory Board from 2012, and Sinopharm Holding Health Development (Shanghai) Co. Ltd., as Member-Supervisory Board from 2012.
Mr. Feng also formerly worked at China National Accord Medicines Corp.
Ltd., as Chairman-Supervisory Board from 2012 to 2016, Sinopharm YiXin Pharmaceutical Co., Ltd., as Director, Sinopharm Group Co., Ltd., as Head-Financial Management from 2010 to 2016, PricewaterhouseCoopers Zhong Tian LLP, as Senior Manager-Audit from 2002 to 2010, and Sinopharm Group Sanyi Pharmaceutical (Wuhu) Co. Ltd., as Member-Supervisory Board.
Mr. Feng received his Masters Business Admin degree in 2015 from China Europe International Business School and undergraduate degree in 2001 from Shanghai University of Finance & Economics.